For research use only. Not for therapeutic Use.
CMO（Cat No.:I025030）is an organic compound containing a fused heterocyclic structure with an oxadiazole ring, which has potential applications in medicinal chemistry and material science. The compound features a chlorobenzo[b]thiophene group and a methoxyphenyl group, which may influence its biological activity, such as antimicrobial, anticancer, or anti-inflammatory properties. The presence of the oxadiazole ring may also provide electronic stability and enhance its reactivity for drug development or as a functional material in organic electronics or sensors. Further research is needed to fully explore its therapeutic and industrial potential.
| Catalog Number | I025030 |
| Synonyms | CMO |
| Molecular Formula | C17H11ClN2O2S |
| Purity | 98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 2-(3-chloro-1-benzothiophen-2-yl)-5-(3-methoxyphenyl)-1,3,4-oxadiazole |
| InChI | InChI=1S/C17H11ClN2O2S/c1-21-11-6-4-5-10(9-11)16-19-20-17(22-16)15-14(18)12-7-2-3-8-13(12)23-15/h2-9H,1H3 |
| InChIKey | RKNVFVPJGGFNAP-UHFFFAOYSA-N |
| SMILES | COC1=CC=CC(=C1)C2=NN=C(O2)C3=C(C4=CC=CC=C4S3)Cl |
